ArticleExperimental and therapeutic medicine2015

EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway.

Mengyao Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.